English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 45351/58527 (77%)
造訪人次 : 2507649      線上人數 : 251
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    請使用永久網址來引用或連結此文件: http://libir.tmu.edu.tw/handle/987654321/5856


    題名: 三亞麻油酸抑制心肌細胞肥厚相關機轉之探討
    The mechanisms of inhibitory effect of trilinolein on cardiomyocyte hypertrophy
    作者: 劉如濟
    Ju-Chi Liu
    貢獻者: 醫學研究所
    關鍵詞: 心臟肥厚
    三亞麻油酸
    血管張力素-II
    正腎上腺素
    活性氧自由基族群
    cardiac hypertrophy
    trilinolein
    angiotensin II
    norepinephrine
    reactive oxygen specis
    日期: 2006
    上傳時間: 2009-09-11 15:45:15 (UTC+8)
    摘要: 心臟肥厚 (cardiac hypertrophy) 是心血管疾病的重要表徵。在臨床上心臟肥厚會導致心臟功能衰竭、心律不整、甚至猝死。許多研究證實心臟肥厚與氧自由基的生成有關。三亞麻油酸 (trilinolein) 是一種存在於植物的“不飽和脂肪酸”。在傳統中藥“川七”的根部富含此種脂肪酸,而“川七”在中國用來治療心血管疾病已有數百年歷史。國內經由陳保羅教授,鄭瑞棠教授及洪傳岳教授多年的研究已證實三亞麻油酸具有抗氧化作用,可保護心血管細胞遭受缺氧時的傷害。然而對三亞麻油酸在心血管細胞內的分子生物學作用機轉卻不清楚。本研究目的即探討三亞麻油酸是否會經由其抗氧化之作用來抑制心肌細胞肥厚之發生? 如果有此抑制作用,其細胞內相關之訊息傳遞及分子機轉為何? 我們以大白鼠心室之組織作心肌細胞(cardiomyocyte) 的培養。以血管張力素-Ⅱ (Angiotensin -Ⅱ) 或正腎上腺素 (Norepinephrine) 刺激心肌細胞,發現心肌細胞的活性氧自由基族群 (reactive oxygen species ; ROS) 會呈劑量相關性的有意義增加。而如先以三亞麻油酸處理的心肌細胞,血管張力素-Ⅱ或正腎上腺素所刺激ROS的生成會被抑制。同樣,血管張力素-Ⅱ或正腎上腺素所增加的心肌細胞蛋白質合成作用及肥厚相關基因β-myosin heavy chain ( β-MyHC) 的基因表現也會被三亞麻油酸所抑制。在訊息傳遞機轉方面,我們檢測mitogen-activated protein kinases (MAPKs) 的磷酸化,發現三亞麻油酸可有意義地抑制血管張力素-Ⅱ或正腎上腺素所導致的MAPKs 磷酸化現象。而血管張力素-Ⅱ所增加的轉錄因子nuclear factor-kappa B或activator protein-1 的活性,也會被三亞麻油酸所抑制。而以上三亞麻油酸所產生的心肌細胞肥厚相關機轉的抑制作用,如以其它的抗氧化劑如N-acetyl-cysteine (NAC) 亦可有相同的抑制作用,表示三亞麻油酸對心肌細胞肥厚的抑制與其抗氧化能力有關。
    Cardiac hypertrophy is a major clinical feature of many cardiovascular diseases. Cardiac hypertrophy can cause heart dysfunction, cardiac arrhythmia, and even sudden death. Trilinolein, an unsaturated triacylglyceride, is found in the root of Sanchi (Panax notoginseng), which has been used as a traditional herbal medicine for treating cardiovascular disorder among Chinese for hundreds of years. Previous studies have demonstrated that trilinolein possessed antioxidative ability, which protected cardiovascular cells against hypoxic injury. However, the intracellular molecular mechanisms of these protective effects of trilinolein on cardiovascular system are still unclear now. The aims of this research were attempt to investigate whether trilinolein could inhibit cardiac hypertrophy via its ability of antioxidation? And if trilinolein could inhibit cardiac hypertrophy, we want to identify the underlying signal transduction pathways and intracellular molecular mechanisms. Cultured neonatal rat cardiomyocytes were stimulated with norepinephrine or angiotensin II. We found that reactive oxygen species were significantly increased in a dose-dependent manner by norepinephrine and angiotensin II. Pretreatment with trilinolein significantly attenuated the norepinephrine- or angiotensin II-induced reactive oxygen species generation in cardiomyocytes. Protein synthesis (by assay of [3H]-leucine incorporation) and hypertrophy related gene expression (by measurement of the beta-myosin heavy chain promoter activity) were examined. Trilinolein significantly inhibited norepinephrine- or angiotensin II-increased protein synthesis, and beta-myosin heavy chain promoter activity. Other antioxidant, N-acetylcysteine (NAC), also significantly inhibited norepinephrine- or angiotensin II-increased protein synthesis, and beta-myosin heavy chain promoter activity. Furthermore, both trilinolein and N-acetylcysteine decreased norepinephrine- or angiotensin II-activated mitogen-activated protein kinases phosphorylation. And trilinolein and NAC also significant inhibited angiotensin II-stimulated transcriptional factors activities (activator protein-1-, or nuclear factor-kappa B- luciferase reporter binding activities). These data indicate that trilinolein inhibits norepinephrine- or angiotensin II-induced cardiomyocyte hypertrophy via its ability of attenuation of reactive oxygen species generation.
    資料類型: thesis
    顯示於類別:[醫學科學研究所] 博碩士論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    摘要.doc35KbMicrosoft Word113檢視/開啟
    摘要.pdf69KbAdobe PDF117檢視/開啟
    摘要.ppt112KbMicrosoft Powerpoint180檢視/開啟
    摘要.ps398KbPostscript56檢視/開啟


    在TMUIR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    著作權聲明 Copyright Notice
    • 本平台之數位內容為臺北醫學大學所收錄之機構典藏,包含體系內各式學術著作及學術產出。秉持開放取用的精神,提供使用者進行資料檢索、下載與取用,惟仍請適度、合理地於合法範圍內使用本平台之內容,以尊重著作權人之權益。商業上之利用,請先取得著作權人之授權。

      The digital content on this platform is part of the Taipei Medical University Institutional Repository, featuring various academic works and outputs from the institution. It offers free access to academic research and public education for non-commercial use. Please use the content appropriately and within legal boundaries to respect copyright owners' rights. For commercial use, please obtain prior authorization from the copyright owner.

    • 瀏覽或使用本平台,視同使用者已完全接受並瞭解聲明中所有規範、中華民國相關法規、一切國際網路規定及使用慣例,並不得為任何不法目的使用TMUIR。

      By utilising the platform, users are deemed to have fully accepted and understood all the regulations set out in the statement, relevant laws of the Republic of China, all international internet regulations, and usage conventions. Furthermore, users must not use TMUIR for any illegal purposes.

    • 本平台盡力防止侵害著作權人之權益。若發現本平台之數位內容有侵害著作權人權益情事者,煩請權利人通知本平台維護人員([email protected]),將立即採取移除該數位著作等補救措施。

      TMUIR is made to protect the interests of copyright owners. If you believe that any material on the website infringes copyright, please contact our staff([email protected]). We will remove the work from the repository.

    Back to Top
    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋